SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-17-005401
Filing Date
2017-05-17
Accepted
2017-05-17 09:15:24
Documents
4
Period of Report
2017-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k051117_optimizerxcorp.htm 8-K 32308
2 SEPARATION AND STOCK PURCHASE AGREEMENT, DATED MAY 11, 2017 f8k051117ex10i_optimizerx.htm EX-10.1 40082
3 PRESS RELEASE, DATED MAY 17, 2017 f8k051117ex99i_optimizerx.htm EX-99.1 18293
4 GRAPHIC ex99i.jpg GRAPHIC 19504
  Complete submission text file 0001213900-17-005401.txt   118967
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53605 | Film No.: 17850382
SIC: 7389 Services-Business Services, NEC